ASHAP salvage therapy for recurrent and refractory Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL).

被引：0
|
作者：
Hanel, M
Hoffknecht, MM
Peters, SO
Fiedler, F
Hanel, A
Kruger, WH
Zeller, W
Braumann, D
Illiger, HJ
Metzner, B
Schubert, JC
Schmitz, N
Weh, HJ
Kroger, N
Zander, AR
机构：
[1] KUCHWALDKRANKENHAUS,CLIN INTERNAL MED 3,DEPT HEMATOL,CHEMNITZ,GERMANY
[2] UNIV HAMBURG,HOSP EPPENDORF,BMT CTR,D-20246 HAMBURG,GERMANY
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4559 / 4559
页数：1
相关论文
共 50 条
  • [21] Epidemiology of Hodgkin's disease and non-Hodgkin's lymphoma
    Swerdlow, A. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (Suppl 1) : S3 - S12
  • [22] Dexamethasone, etoposide, ifosfarnide and cisplatin (DVIP) as salvage therapy in non-Hodgkin's lymphoma and Hodgkin's disease.
    Chubar, Yevgene
    Gavish, Israel
    Yegena, Shay
    Bennett, Michael
    BLOOD, 2006, 108 (11) : 246B - 246B
  • [23] Epidemiology of Hodgkin's disease and non-Hodgkin's lymphoma
    A. J. Swerdlow
    European Journal of Nuclear Medicine and Molecular Imaging, 2003, 30 : S3 - S12
  • [24] CNS involvement in non-Hodgkin's lymphoma (NHL)
    Keldsen, N
    Michalski, W
    Bentzen, SM
    Thorling, K
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 791 - 791
  • [25] ANGIOGENESIS IN INDOLENT NON-HODGKIN'S LYMPHOMA (NHL)
    Minoia, C.
    Zito, F. A.
    Quero, C.
    Rana, A.
    Lacobazzi, A.
    Lapietra, A.
    Giannoccaro, M.
    Daniele, G.
    Ferrucci, A.
    Guarini, A.
    CANCER TREATMENT REVIEWS, 2010, 36 : S117 - S118
  • [26] Angiogenesis in Indolent Non-Hodgkin's Lymphoma (NHL)
    Guarini, A.
    Minoia, C.
    Iacobazzi, A.
    Rana, A.
    Lapietra, A.
    Daniele, G.
    Ferrucci, A.
    Popescu, O.
    Labriola, A.
    Zito, F. A.
    ONCOLOGY, 2009, 77 : 148 - 148
  • [27] ANGIOGENESIS IN INDOLENT NON-HODGKIN'S LYMPHOMA (NHL)
    Guarini, A.
    Minoia, C.
    Iacobazzi, A.
    Rana, A.
    Lapietra, A.
    Giannoccaro, M.
    Ferrucci, A.
    Daniele, G.
    Vacca, A.
    Zito, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 610 - 611
  • [28] Non-Hodgkin's lymphoma (NHL) of the oral cavity
    Pecorari, P
    Melato, M
    ANTICANCER RESEARCH, 1998, 18 (2B) : 1299 - 1302
  • [29] Follow-up (FU) policy after treatment for Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL); The patients view
    Watson, AJ
    Pool, C
    Radford, JA
    BRITISH JOURNAL OF CANCER, 1999, 80 : 20 - 20
  • [30] MAGE-A4 expression in Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL).
    Skinnider, BF
    Jungbluth, AA
    Banerjee, D
    Gascoyne, RD
    MODERN PATHOLOGY, 2001, 14 (01) : 179A - 179A
12345